Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
36.46
-0.03 (-0.08%)
At close: Nov 11, 2026, 4:00 PM EST
36.48
+0.02 (0.04%)
After-hours: Nov 11, 2026, 7:30 PM EST
Pacira BioSciences Employees
As of December 31, 2025, Pacira BioSciences had 829 total employees, including 825 full-time and 4 part-time employees. The number of employees increased by 39 or 4.94% compared to the previous year. That makes Pacira BioSciences the 16,232nd largest employer in the world and 2,304th in the United States.
Employees
829
Change (1Y)
39
Growth (1Y)
4.94%
Revenue / Employee
$896,624
Profits / Employee
$45,509
Market Cap
1.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 829 | 39 | 4.94% | 825 | 4 |
| Dec 31, 2024 | 790 | 78 | 10.96% | 788 | 2 |
| Dec 31, 2023 | 712 | -3 | -0.42% | 711 | 1 |
| Dec 31, 2022 | 715 | 18 | 2.58% | 715 | 0 |
| Dec 31, 2021 | 697 | 73 | 11.70% | 697 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,605 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Cronos Group | 610 |
PCRX News
- 3 hours ago - Ingram Micro to replace Pacira in S&P 600 at open on 11/17 - TheFly
- 6 days ago - Pacira BioSciences Quarterly report: Q3 2026 - Filings
- 6 days ago - Viatris Reports Third-Quarter 2026 Financial Results - PRNewsWire
- 12 days ago - Viatris commences tender offer to acquire Pacira for $36.50 per share in cash - TheFly
- 12 days ago - Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. - PRNewsWire
- 4 weeks ago - Pacira price target raised to $36.50 from $25 at RBC Capital - TheFly
- 4 weeks ago - Pacira downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 weeks ago - Pacira downgraded to Hold from Buy at Truist - TheFly